Latham & Watkins Advises Underwriters in Phreesia’s Public Offering of Common Stock

Multidisciplinary team represented the underwriters in the offering by the patient intake management platform.

April 13, 2021

Phreesia, Inc., a leading patient intake management platform, has announced the closing of the underwritten public offering of 5,175,000 shares of its common stock all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of US$50 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount. The Company received net proceeds from the offering of approximately US$245.3 million after deducting underwriting discounts and estimated offering expenses.

Latham & Watkins LLP represented the underwriters in the offering with a capital markets team led by New York partner Stelios Saffos, with associates Brittany Ruiz, Brian Yoon, and Egzon Sulejmani. Advice was also provided on tax matters by New York partner Jiyeon Lee-Lim, with associate Ron Moore; on payments matters by Washington, D.C. partner Todd Beauchamp, with associate Loyal Horsley; and on data privacy and cybersecurity matters by Washington, D.C. partner Jennifer Archie, with counsel Marissa Boynton.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.